These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2623542

  • 1. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann G, Ranft J.
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract] [Full Text] [Related]

  • 2. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G.
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T, Griesshaber J, Rogatti W, Kistner O, Hsu E, Jansen T, Diehm C.
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [Abstract] [Full Text] [Related]

  • 4. [Prostaglandin E1 in intermittent claudication].
    Scheffler P, de la Hamette D, Rogatti W.
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract] [Full Text] [Related]

  • 5. [Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann M, Ranft J.
    Vasa; 1991; 20(1):13-6. PubMed ID: 2031393
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P, Birkel L, Grub KR, de la Hamette D.
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD.
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H, Diehm C, Grom E, Martin M, Mörl H, Rudofsky G, Vogelberg KH.
    Vasa Suppl; 1992 Jun; 35():164-6. PubMed ID: 1481031
    [No Abstract] [Full Text] [Related]

  • 13. [Short- and long-term evaluation of treatment of critical ischemia of the lower lim with PGE1 (alprostadyl alpha-cyclodestrine)].
    Amitrano M, Izzo M, Castaldo G, Lombardi R, Tizzano R, Bellizzi AM, Vietri GC, Sorrentino A, D'Avanzo A.
    Minerva Cardioangiol; 1996 Jun; 44(7-8):391-6. PubMed ID: 8965998
    [Abstract] [Full Text] [Related]

  • 14. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A, Arnold A, Caspary L, Thum J, Alexander K.
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [Abstract] [Full Text] [Related]

  • 15. [Prostaglandin E1 in treatment of incomplete ischemia syndromes of the lower extremity].
    Vogelpohl M, Nobbe F.
    Vasa Suppl; 1991 May; 32():377-82. PubMed ID: 1771539
    [No Abstract] [Full Text] [Related]

  • 16. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
    Redecker M, Heinrich F, Fenn K.
    Vasa Suppl; 1988 May; 23():182-5. PubMed ID: 3206334
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L, Vranes M, Cernak I, Kostić D, Lovrić A, Sagić D, Lotina S.
    Srp Arh Celok Lek; 1992 May; 120(1-2):9-14. PubMed ID: 1641706
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.